Candriam Equities L Oncology Impact C/ LU1864481541 /
| NAV16/05/2024 | Diferencia+0.2200 | Tipo de beneficio | Enfoque de la inversión | Sociedad de fondos |
|---|---|---|---|---|
| 236.2900USD | +0.09% | paying dividend | Equity Worldwide | Candriam ▶ |
Rendimiento mensual
| ene. | feb. | mar. | abr. | may. | jun. | jul. | ago. | sep. | oct. | nov. | dic. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019 | - | 6.11 | 2.59 | -3.71 | -2.64 | 8.63 | 0.22 | -0.35 | -3.24 | 5.02 | 7.89 | 4.95 | +30.34% |
| 2020 | -1.52 | -5.41 | -3.15 | 12.05 | 8.47 | 1.34 | 4.36 | 2.08 | 3.44 | -2.27 | 5.74 | 3.79 | +31.33% |
| 2021 | 0.48 | -4.26 | -0.16 | 2.26 | 0.10 | 3.44 | -1.04 | 5.49 | -3.84 | 3.30 | -6.44 | 3.90 | +2.49% |
| 2022 | -10.55 | -1.82 | 4.57 | -5.92 | -1.41 | -0.04 | 4.29 | -3.22 | -4.78 | 6.96 | 5.99 | -3.52 | -10.50% |
| 2023 | 2.07 | -3.95 | 1.30 | 2.76 | -2.64 | 0.00 | 0.81 | -2.09 | -5.31 | -6.44 | 9.13 | 5.65 | +0.17% |
| 2024 | 1.29 | 4.06 | 1.42 | -3.47 | 4.96 | - | - | - | - | - | - | - | - |
Meses individuales: Dividendos no considerados
Valores estimados
| Año hasta la fecha | 6 Meses | Promedio móvil | 3 Años | 5 Años | |
|---|---|---|---|---|---|
| Volatilidad | 10.88% | 10.93% | 11.81% | 14.68% | 17.25% |
| Índice de Sharpe | 1.86 | 3.39 | 0.21 | -0.21 | 0.34 |
| El mes mejor | +5.65% | +9.13% | +9.13% | +9.13% | +12.05% |
| El mes peor | -3.47% | -3.47% | -6.44% | -10.55% | -10.55% |
| Pérdida máxima | -6.87% | -6.87% | -16.24% | -26.56% | -26.56% |
| Rendimiento superior | - | - | - | - | - |
Todas las cotizaciones en USD
Tramos
| Nombre | Tipo de beneficio | Prec. de rescate | Promedio móvil | 3 Años | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,400.9099 | +7.62% | +6.05% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,565.5000 | +7.75% | +6.45% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.9700 | +4.02% | -4.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,252.5000 | +5.81% | +17.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,611.3000 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 245.4500 | +6.23% | +14.09% | |
| Candriam Equities L Oncology Imp... | paying dividend | 236.2900 | +6.27% | +2.13% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.3300 | +7.17% | +4.73% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,796.0000 | +3.23% | +2.32% | |
| Candriam Equities L Oncology Imp... | reinvestment | 159.3600 | +5.69% | +16.70% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,114.3201 | +5.00% | -2.15% | |
| Candriam Equities L Oncology Imp... | reinvestment | 260.0600 | +7.14% | +17.01% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4600 | +3.60% | -5.99% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.8900 | +7.16% | +4.72% | |
| Candriam Equities L Oncology Imp... | reinvestment | 194.1900 | +4.88% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,857.8800 | +6.15% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,884.1399 | +7.27% | +5.03% | |
| Candriam Equities L Oncology Imp... | reinvestment | 157.8100 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.5300 | +6.26% | +2.11% |
Performance
| Año hasta la fecha | +8.31% | ||
|---|---|---|---|
| 6 Meses | +18.51% | ||
| Promedio móvil | +6.27% | ||
| 3 Años | +2.13% | ||
| 5 Años | +58.81% | ||
| 10 Años | - | ||
| Desde el principio | +70.35% | ||
| Año | |||
| 2023 | +0.17% | ||
| 2022 | -10.50% | ||
| 2021 | +2.49% | ||
| 2020 | +31.33% | ||
| 2019 | +30.34% | ||
Dividendos
| 29/04/2024 | 4.55 USD |
| 28/04/2023 | 3.39 USD |
| 28/04/2022 | 4.28 USD |
| 28/04/2021 | 4.15 USD |
| 24/04/2020 | 1.50 USD |
